


Aurora Biosynthetics Revenue
Biotechnology Research • • 1-10 Employees
Aurora Biosynthetics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at Aurora Biosynthetics
Steven Yatomi-Clarke
Chief Executive Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Aurora Biosynthetics Email Formats
Aurora Biosynthetics uses 1 email format. The most common is {first initial} (e.g., j@aurorabiosynthetics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@aurorabiosynthetics.com | 100% |
About Aurora Biosynthetics
Aurora Biosynthetics is a state-of-the-art RNA manufacturing partner providing comprehensive, end-to-end solutions for the production of critical drug components, including plasmid DNA, mRNA, and lipid nanoparticles (LNPs). Located in Sydney, Australia, Aurora integrates process and analytical development, GMP manufacturing, and fill/finish services under one roof. This streamlined approach significantly reduces manufacturing risks and accelerates timelines, enabling biotechnology and pharmaceutical companies worldwide to rapidly advance their innovative RNA-based therapies. Leveraging strategic public-private partnerships and deep industry expertise, Aurora is uniquely positioned to address the growing global demand for reliable, high-quality RNA manufacturing solutions.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Aurora Biosynthetics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Aurora Biosynthetics has never raised funding before.
Frequently asked questions
4.8
40,000 users



